Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $58.5 million.

  • Bio's Total Non-Current Liabilities rose 111.19% to $58.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.5 million, marking a year-over-year increase of 111.19%. This contributed to the annual value of $56.7 million for FY2024, which is 132.22% down from last year.
  • Bio's Total Non-Current Liabilities amounted to $58.5 million in Q3 2025, which was up 111.19% from $57.1 million recorded in Q2 2025.
  • In the past 5 years, Bio's Total Non-Current Liabilities ranged from a high of $58.5 million in Q3 2025 and a low of $36.6 million during Q1 2021
  • Its 5-year average for Total Non-Current Liabilities is $51.6 million, with a median of $55.0 million in 2022.
  • In the last 5 years, Bio's Total Non-Current Liabilities surged by 3511.26% in 2022 and then plummeted by 132.22% in 2024.
  • Over the past 5 years, Bio's Total Non-Current Liabilities (Quarter) stood at $42.1 million in 2021, then increased by 24.37% to $52.3 million in 2022, then grew by 9.87% to $57.5 million in 2023, then decreased by 1.32% to $56.7 million in 2024, then increased by 3.08% to $58.5 million in 2025.
  • Its Total Non-Current Liabilities was $58.5 million in Q3 2025, compared to $57.1 million in Q2 2025 and $57.8 million in Q1 2025.